Cogent Biosciences, Inc. · NASDAQ:COGT
Venrock Healthcare Capital Partners II, L.P. reported a 5.80% stake in Cogent Biosciences, Inc. (Schedule 13G/A)
Event Sep 30, 2024 · Filed Apr 11, 2025
Venrock Healthcare Capital Partners II, L.P. reported a 5.80% stake in Cogent Biosciences, Inc., 6,446,917 shares, as a passive investor on Sep 30, 2024. Filed Apr 11, 2025 (Schedule 13G/A).
- Stake
- 5.80%
- Shares
- 6,446,917
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Venrock Healthcare Capital Partners II, L.P. | 5.80% | 6,446,917 |
| VHCP Co-Investment Holdings II, LLC | 5.80% | 6,446,917 |
| VHCP Management II, LLC | 5.80% | 6,446,917 |
| Venrock Healthcare Capital Partners III, L.P. | 5.80% | 6,446,917 |
| VHCP Co-Investment Holdings III, LLC | 5.80% | 6,446,917 |
| Venrock Healthcare Capital Partners EG, L.P. | 5.80% | 6,446,917 |
| VHCP Management III, LLC | 5.80% | 6,446,917 |
| VHCP Management EG, LLC | 5.80% | 6,446,917 |
| Nimish Shah | 5.80% | 6,446,917 |
| Bong Y Koh | 5.80% | 6,446,917 |
Source
Related
- Cogent Biosciences, Inc.
- Venrock Healthcare Capital Partners II, L.P.
- Cogent Biosciences, Inc. shareholders
- Schedule 13G/A · Venrock Healthcare Capital Partners II, L.P. · Aug 14, 2025
- Form 4 · Morris Arlene · Aug 31, 2026
- Schedule 13G/A · Deerfield Mgmt, L.P. · Aug 13, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Robbins Andrew R · May 21, 2026